Peripheral Artery Disease Market - Global Opportunity Analysis and Industry Forecast 2020-2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peripheral Artery Disease Market by Type, Global Opportunity Analysis and Industry Forecast, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering.

At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.

Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries. Generally, it affects arteries in the legs and sometimes affect the arteries carrying blood from heart to arms, kidneys, head, and stomach. It is mainly caused by the deposition of fats or plaques in the artery walls. The exercise, tobacco cessation, and a healthy diet are the main treatments for this disease; however, when such treatments aren't enough, medication or surgery can be helpful.

Market Dynamics and Trends:

Factors such as huge geriatric population, widespread unhealthy lifestyle choices, and rise in new products approvals in the field of peripheral artery disease drive the growth of the market. In addition, high risk factors including diabetes and smoking contributes to the upsurged incidences of peripheral arterial diseases, further propelling the market growth.

However, the concern of restenosis, the reoccurrence of peripheral artery disease (PAD) even after the treatment may hamper growth of the market to some extent. On the other hand, continually changing lifestyle habits including unhealthy dietary habits, excessive alcohol consumption, and lack of physical activity also makes people more vulnerable to PAD and thus, boosts the market growth.

Geographical Analysis:

In terms of geography, North America held major share of the market in 2019. This is attributed to higher healthcare expenditure and the growing occurrence of minimally invasive surgeries in the region.

However, Asia-pacific is expected to be the fastest growing market due to the existence of large patient pool along with unmet medical needs. Moreover, significant growth in population together with growing geriatric population is expected to be opportunistic for the market growth in this region during the forecast period.

Competitive Landscape:

Lucrative growth opportunities make the peripheral artery disease market highly competitive. Some of the major players in the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips N.V, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG. and many more.

A number of developmental strategies have been adopted by companies in the past few years. For instance, in September 2020, Abbott Laboratories started the LIFE-BTK clinical trial to assess the effectiveness and safety of its Esprit BTK Everolimus Eluting Resorbable Scaffold System. This is the Investigational Device Exemption (IDE) trial in the U.S. that is expected to help people battling the advanced stages of peripheral artery disease (PAD).

Also, in June 2020, Becton, Dickinson and Company acquired Straub Medical AG, a private company. Straub Medical AG develops medical atherectomy & thrombectomy devices for the treatment of venous disease and peripheral arterial disease (PAD). This acquisition strengthens peripheral artery disease treatment capabilities of the Becton, Dickinson and Company.

Key Topics Covered:

1. Introduction

1.1. Report Description

1.2. Research Methodology

2. Market Snapshot, 2019-2030 Million USD

2.1. Market Snapshot

3. Porter's Five Force Model Analysis

4. Market Dynamics

4.1. Growth Drivers

4.2. Challenges

4.3. Opportunities

5. Global Peripheral Artery Disease Market, by Type

5.1. Overview

5.2. Peripheral Angioplasty Balloons

5.2.1 Global Peripheral Angioplasty Balloons Market, by Type

5.2.1.1 Old/Normal Balloons Market

5.2.1.2 Cutting & Scoring Balloons Market

5.2.1.3 Drug-Coated Balloons Market

5.2.2 Peripheral Angioplasty Balloons Market

5.3. Peripheral Stents

5.3.1 Global Peripheral Stents Market, by Type

5.3.1.1 Self-Expandable Market

5.3.1.2 Balloon-Expandable Market

5.3.1.3 Covered Stents Market

5.3.1.4 Drug-Eluting Stents Market

5.3.2 Peripheral Stents Market

5.4. Peripheral Catheters

5.4.1 Global Peripheral Catheters Market, by Type

5.4.1.1 Angiography Catheters Market

5.4.1.2 Guiding Catheters Market

5.4.2 Peripheral Catheters Market

5.5. Inferior Vena Cava (Ivc) Filters

5.5.1 Global Inferior Vena Cava (Ivc) Filters Market, by Type

5.5.1.1 Permanent Filters Market

5.5.1.2 Retrievable Filters Market

5.5.2 Inferior Vena Cava (Ivc) Filters Market

5.6. Plaque Modification Devices

5.6.1 Global Plaque Modification Devices Market, by Type

5.6.1.1 Thrombectomy Devices Market

5.6.1.2 Atherectomy Devices Market

5.6.2 Plaque Modification Devices Market

6. Global Peripheral Artery Disease Market, by Region

6.1. Overview

7. Company Profiles

• Abbott Laboratories
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Terumo Corporation
• Cook Medical
• Becton, Dickinson and Company
• Koninklijke Philips N.V
• AngioDynamics, Inc.
• BIOTRONIK,
• B. Braun Melsungen AG.

For more information about this report visit https://www.researchandmarkets.com/r/vt52mg